HTX Opens Trading for ZEST (Zest Protocol)
Panama City, Panama--(Newsfile Corp. - May 19, 2026) - HTX, a leading global cryptocurrency exchange, announced the listing of ZEST (Zest Protocol) on May 19. ZEST/USDT spot trading and ZEST/USDT (10X) isolated margin trading are now available to users on HTX.
Zest Protocol is a Bitcoin lending protocol that enables Bitcoin liquidity providers to earn Bitcoin yield through professionally managed lending pools.
ZEST is the native utility token of Zest Protocol, which has a total supply of 1 billion tokens. Holders will be able to participate in governance and staking when such features go live.
About HTX
Founded in 2013, HTX has evolved from a virtual asset exchange into a comprehensive ecosystem of blockchain businesses that span digital asset trading, financial derivatives, research, investments, incubation, and other businesses.
As a world-leading gateway to Web3, HTX harbors global capabilities that enable it to provide users with safe and reliable services. Adhering to the growth strategy of "Global Expansion, Thriving Ecosystem, Wealth Effect, Security & Compliance," HTX is dedicated to providing quality services and values to virtual asset enthusiasts worldwide.
To learn more about HTX, please visit https://www.htx.com/ or HTX Square. For further inquiries, please contact [email protected].
Find us on
Twitter:
https://twitter.com/htxfutures
Facebook: https://www.facebook.com/htxglobalofficial/
Instagram: https://www.instagram.com/htxglobalofficial/
Reddit: https://www.reddit.com/r/HuobiGlobal/
Medium: https://htxofficial.medium.com/
Telegram:
https://t.me/htxglobalofficial
https://t.me/HTXGlobalAnnouncementChannel
Discord
https://discord.gg/htx-official

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297967
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Huntington Ingalls wins $418M Navy contract
- Beyond the IGV Swing Lies the Rise of AI Application Leaders Like Tec-Do
- MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026
Create E-mail Alert Related Categories
Newsfile, Press ReleasesRelated Entities
Twitter, Bitcoin, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share